Evidence & regulatory context
- Mechanism
- Not recorded
- Target
- Not recorded
- Injury models
- Spinal cord injury
- Reported indication
- Not recorded
- First approval
- Not recorded
- Development stage
- Not recorded
- ChEMBL record
- Not recorded
- ChEMBL max phase
- Not recorded
- Synonyms
- Not recorded
- Note
- Not recorded
Clinical trials 1
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
Isolation, Quantification and Kinetics of Salivary Ap4A, SCCA and TROP2 in Patients With Oral Cancer and Potentially Malignant Oral Disorders
Oral Cavity Squamous Cell Carcinoma · Saliva Altered · Precancerous Lesions
Enrolment: 100 · Results not recorded
Preclinical evidence 1
1 studies reported at therapy level; 1 evidence entries itemised.
MouseSpinal cord injuryContusionintraspinal administration in vivo; in vitro experiments in Neuro2a cellsacute administration following SCI, exact time point not specified in available…
Model: moderate contusive spinal cord injury
Ap4A reduced ATP-dependent excitotoxic death in Neuro2a cells by lowering intracellular calcium responses and purinergic receptor expression, and acute administration after contusive SCI in mice reduced tissue damage and improved motor function recovery.
Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.5. Machine-extracted fields require source verification.